Long-acting β₂ agonists in asthma and allergic rhinitis

Bibliography

• Nelson HS. β-Adrenergic bronchodilators. N Engl J Med 1995;33:499-506
   Google Scholar
• Waldeck B. Some pharmacodynamic aspects on long-acting β-adrenoceptor agonists. Gen Pharmacol 1996;27;575-80
   PubMedGoogle Scholar
• Waldeck B. β-Adrenoceptor agonists and asthma: 100 years of development. Eur J Pharmacol 2002;445:1-12
   PubMed Web of Science ®Google Scholar
• Hanania NA, Sharafkhaneh A, Barber R, Dickey BF. β-Agonist intrinsic efficacy: measurement and clinical significance. Am J Respir Crit Care Med 2002;165:1353-8
   PubMed Web of Science ®Google Scholar
• Hanania NA, Moore RH. Anti-inflammatory activities of β2-agonists. Curr Drug Targets Inflamm Allergy 2004;3:271-7
   PubMedGoogle Scholar
• Butchers PR, Vardey CJ, Johnson M. Salmeterol: a potent and long-acting inhibitor of inflammatory mediator release from human lung. Br J Pharmacol 1991;104:672-6
   PubMed Web of Science ®Google Scholar
• Kaur M, Chivers JE, Giembycz MA, Newton R. Long-acting β2-adrenoceptor agonists synergistically enhance glucocorticoid-dependent transcription in human airways epithelial and smooth muscle cells. Mol Pharmacol 2008;73:203-14
   PubMed Web of Science ®Google Scholar
• Bateman ED, Hurd SS, Barnes PJ, et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 2008;31:143-78
   PubMed Web of Science ®Google Scholar
• National Asthma Education and Prevention Program. Expert Panel Report 3 (EPR-3): guidelines for the diagnosis and management of asthma-summary report 2007. J Allergy Clin Immunol 2007;120(5 Suppl):S94-138
   PubMed Web of Science ®Google Scholar
• Donohue JF. Therapeutic responses in asthma and COPD: bronchodilators. Chest 2004;126:S125-37
   PubMedGoogle Scholar
• Donohue JF, Fromer L. Long-acting β-agonists role in asthma management. J Fam Pract 2006;(Suppl):1-6
   PubMed Web of Science ®Google Scholar
• Yates DH, Sussman HS, Shaw MJ, et al. Regular formoterol treatment in mild asthma: effect on bronchial responsiveness during and after treatment. Am J Respir Crit Care Med 1995;152:1170-4
   PubMed Web of Science ®Google Scholar
• Cheung D, Timmers MC, Zwinderman AH, et al. Long-term effects of long-acting β2 adrenoceptor agonist salmeterol on airway hyperresponsiveness in patients with mild asthma. N Engl J Med 1992;327:1198-203
   PubMed Web of Science ®Google Scholar
• Greenstone IR, Ni Chroinin MN, Masse V, et al. Combination of inhaled long-acting β2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma. Cochrane Database Syst Rev 2005;(4):CD005533
   PubMedGoogle Scholar
• Martinez FD. Safety of long-acting β-agonists: an urgent need to clear the air. N Engl J Med 2005;353:2637-9
   PubMed Web of Science ®Google Scholar
• Castle W, Fuller R, Hall J, Palmer J. Serevent nationwide surveillance study: comparison of salmeterol with salbutamol in asthmatic patients who require regular bronchodilator treatment. BMJ 1993;306:1034-7
   PubMed Web of Science ®Google Scholar
• Spitzer WO, Suissa S, Ernst P, et al. The use of β-agonists and the risk of death and near death from asthma. N Engl J Med 1992;326:501-6
   PubMed Web of Science ®Google Scholar
• Nelson HS, Weiss ST, Bleecker ER, et al. The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. Chest 2006;129:15-26
   PubMed Web of Science ®Google Scholar
• Salpeter SR, Buckley NS, Ormiston TM, Salpeter EE. Meta-analysis: effect of long-acting β-agonists on severe asthma exacerbations and asthma related deaths. Ann Intern Med 2006;144:904-12
   PubMed Web of Science ®Google Scholar
• FitzGerald JM, Gibson PG. Asthma exacerbations. 4: Prevention. Thorax 2006;61:992-9
   PubMed Web of Science ®Google Scholar
• Krouse JH, Brown RW, Fineman SM, et al. Asthma and the unified airway. Otolaryngol Head Neck Surg 2007;138:S76-108
   Google Scholar
• Sarin S, Undem B, Sanico A, Togias A. The role of the nervous system in rhinitis. J Allergy Clin Immunol 2006;118:999-1014
   PubMed Web of Science ®Google Scholar
• Togias A. Rhinitis and asthma: evidence for respiratory system integration. J Allergy Clin Immunol 2003;111:1171-84
   PubMed Web of Science ®Google Scholar
• Passalacqua G, Ciprandi G, Canonica GW. United airway diseases: therapeutic aspect. Thorax 2005;55:526-7
   Google Scholar
• Fontanari P, Burnet H, Zattara-Hartmann MC, Jammes Y. Changes in airway resistance induced by nasal inhalation of cold dry, dry, or moist air in normal individuals. J Appl Physiol 1996;81:1739-43
   PubMed Web of Science ®Google Scholar
• Bousquet J, Khaltaev N, Cruz AA, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA2;LEN and AllerGen). Allergy 2008;63(Suppl 86):8-160
   PubMed Web of Science ®Google Scholar
• Settipane RJ, Hagy GY, Settipane GA. Long-term risk factor for developing asthma and allergic rhinitis: a 23-year follow-up of college students. Allergy Proc 1994;15:21-5
   PubMedGoogle Scholar
• Pillsbury HC 3rd, Krouse JH, Marple BF, Parker MJ. The impact/role of asthma in otorinolaryngology. Otolaryngol Head Neck Surg 2007;136:157
   PubMed Web of Science ®Google Scholar
• Madonini E, Briatico-Vangosa G, Pappacoda A, et al. Seasonal increase in bronchial reactivity in allergic rhinitis. J Allergy Clin Immunol 1987;79:358-63
   PubMed Web of Science ®Google Scholar
• Huse DM, Harte SC, Russel MW, et al. Allergic rhinitis may worsen asthma symptoms in children: the International Asthma Outcomes Registry. Am J Resp Care Med 1996;153:A860
   Google Scholar
• Pawankar R. Allergic rhinitis and asthma: are they manifestations of one syndrome? Clin Exp Allergy 2006;36:1-4
   PubMed Web of Science ®Google Scholar
• Braunstahl GJ, Overbeek SE, Fokkens WJ, et al. Segmental bronchoprovocation in allergic rhinitis patients affects mast cell and basophil numbers in nasal and bronchial mucosa. Am J Respir Crit Car Med 2001;164:858-65
   PubMed Web of Science ®Google Scholar
• Black JL, Roth M, Lee J, et al. Mechanisms of airway remodeling: airway smooth muscle. Am J Respir Crit Care Med 2001;164:S63-6
   Google Scholar
• Chakir J, Laviolette M, Boutet M, et al. Lower airways remodeling in nonasthmatic subjects with allergic rhinitis. Lab Invest 1996;75:735-44
   PubMed Web of Science ®Google Scholar
• Benson M, Carlsson B, Carlsson LM, et al. DNA microarray analysis of transforming growth factor-β and related transcripts in nasal biopsies from patients with allergic rhinitis. Cytokine 2002;18:20-5
   PubMed Web of Science ®Google Scholar
• van Toorenenbergen AW, van Wijk RG, Vermeulen AM. Allergen-induced matrix metalloproteinase-9 in nasal lavage fluid. Allergy 1999;54:293-4
   PubMed Web of Science ®Google Scholar
• Amin K, Rinne J, Haahtela T, et al. Inflammatory cell and epithelial characteristics of perennial allergic and nonallergic rhinitis with a symptom history of 1 to 3 years' duration. J Allergy Clin Immunol 2001;107:249-57
   PubMed Web of Science ®Google Scholar
• Stelmach R, do Patrocínio T, Nunes M, et al. Effect of treating allergic rhinitis with corticosteroids in patient with mild-to-moderate asthma. Chest 2005;128:3140-7
   PubMed Web of Science ®Google Scholar
• Hiley CR, Wilson H, Yates MS. Identification of β-adrenoceptors and histamine receptors in the cat nasal vasculature. Acta Otolaryngol 1978;85:444-52
   PubMed Web of Science ®Google Scholar
• Bissonnette EY, Befus AD. Anti-inflammatory effect of β2-agonists: inhibition of TNF-α release from human mast cells. J Allergy Clin Immunol 1997;100:825-31
   PubMed Web of Science ®Google Scholar
• Grönneberg R, Raud J. Effects of local treatment with salmeterol and terbutaline on anti-IgE-induced wheal, flare, and late induration in human skin. Allergy 1996;51:685-92
   PubMed Web of Science ®Google Scholar
• Borum P, Mygind N. Inhibition of the immediate allergic reaction in the nose by β2-adrenostimulant fenoterol. J Allergy Clin Immunol 1980;66:25-32
   PubMed Web of Science ®Google Scholar
• Borum P, Mygind N, Larsen FS. The anti-allergic effect of β-agonist agent fenoterol in the nose. Eur J Respir Dis 1983;128:44-9
   Google Scholar
• Svensson C, Greiff L, Andersson M, et al. Antiallergic actions of high topical doses of terbutaline in human nasal airways. Allergy 1995;50:884-90
   PubMed Web of Science ®Google Scholar
• Corne JM, Linaker CH, Howarth PH, et al. Effects of systemic β-agonist therapy on IgE production in allergic subjects in vivo J Allergy Clin Immunol 1988;102:727-31
   Google Scholar
• Russo C, Zeng D, Prosperini G, et al. Effect of salbutamol on nasal symptoms and mast cell degranulation induced by adenosine 5′ monophosphate nasal challenge. Clin Exp Allergy 2005;35:1192-6
   PubMed Web of Science ®Google Scholar
• Proud D, Reynolds CJ, Lichtenstein LM, et al. Intranasal salmeterol inhibits allergen-induced vascular permeability but not mast cell activation or cellular infiltration. Clin Exp Allergy 1998;28:868-75
   PubMed Web of Science ®Google Scholar
• Holt S, Suder A, Dronfield L, et al. Intranasal β-agonist in allergic rhinitis. Allergy 2000;55:1198-205
   PubMed Web of Science ®Google Scholar
• Ahlström Emanuelsson C, Anderson M, Persson CGA, et al. Effects of topical fomoterol alone and in combination with budesonide in a pollen seasonal model of allergic rhinitis. Respir Med 2007;101:1106-12
   PubMed Web of Science ®Google Scholar
• Parameswaran K, Fanat A, O'Byrne PM. Effects of intranasal fluticasone and salmeterol on allergen-induced nasal responses. Allergy 2006;61:731-6
   PubMed Web of Science ®Google Scholar
• Cazzola M, Matera MG, Lötvall J. Ultra long-acting β2 agonists in development for asthma and chronic obstructive pulmonary disease. Expert Opin Investig Drugs 2005;14:775-83
   PubMed Web of Science ®Google Scholar
• Campbell LM. Once-daily inhaled corticosteroids in mild to moderate asthma: improving acceptance of treatment. Drugs 1999;58(Suppl 4):25-33
   PubMed Web of Science ®Google Scholar
• Matera MG, Cazzola M. Ultra-long-acting β2-adrenoceptor agonists: an emerging therapeutic option for asthma and COPD? Drugs 2007;67:503-15
   PubMed Web of Science ®Google Scholar
• Handley D. The asthma-like pharmacology and toxicology of the (S)-isomers of β-agonists. J Allergy Clin Immunol 1999;104:S69-76
   Web of Science ®Google Scholar